Glass House Brands (GLAS) Other Non-Current Assets (2020 - 2026)

Glass House Brands' (GLAS) quarterly Other Non-Current Assets came in at $435000.0 in Q1 2026, down 83.05% year-on-year from $2.6 million in Q1 2025, and down 58.96% on a QoQ basis from $1.1 million in Q4 2025.

Glass House Brands (GLAS) Other Non-Current Assets (2020 - 2026) Analysis & Trends

Glass House Brands (GLAS) has 7 years of Other Non-Current Assets data on file, last reported at $435000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Assets fell 83.05% year-over-year to $435000.0 in Q1 2026; TTM through Mar 2026 was $435000.0, a 83.05% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 64.67% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $435000.0, down from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for GLAS reached as high as $4.9 million in Q3 2024 and fell as low as $435000.0 in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $3.3 million across 5 years, with a median of $3.6 million in 2023.
  • Across the five-year window, Other Non-Current Assets surged 2187.6% in 2022 and slumped 83.05% in 2026, its largest moves.
  • Year by year, Other Non-Current Assets stood at $4.7 million in 2022, then declined by 4.67% to $4.5 million in 2023, then tumbled by 32.93% to $3.0 million in 2024, then slumped by 64.67% to $1.1 million in 2025, then sank by 58.96% to $435000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $435000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 1.79 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 233.20 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - 169,000.00
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 295.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn 435,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 435,000.00
Dec 31, 2025 1.06 Mn
Sep 30, 2025 1.33 Mn
Jun 30, 2025 2.48 Mn
Mar 31, 2025 2.57 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 4.91 Mn
Jun 30, 2024 4.37 Mn
Mar 31, 2024 4.48 Mn
Dec 31, 2023 4.47 Mn
Sep 30, 2023 3.53 Mn
Jun 30, 2023 3.57 Mn
Mar 31, 2023 4.75 Mn
Dec 31, 2022 4.69 Mn
Sep 30, 2022 3.67 Mn
Jun 30, 2022 3.63 Mn
Mar 31, 2022 3.31 Mn
Dec 31, 2021 2.34 Mn
Sep 30, 2021 160,478.00
Mar 31, 2021 431,409.00